ebook Munafa Stock Market Course + Intraday & FNO calls  

       

AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

Aurobindo Pharma Limited Complete list of announcements declared & dividend announcements by Aurobindo Pharma Limited AUROPHARMA

Aurobindo Pharma Limited AUROPHARMA listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Aurobindo Pharma Limited AUROPHARMA

Company Announcement
Aurobindo Pharma Limited has informed the Exchange about Completion of US FDA Inspection at Unit-II of Apitoria Pharma Private Limited, a wholly owned subsidiary of the Company.
Announcement as on 16 September 2026

JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?
JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The brokerage expects stronger earnings growth, business diversification and new product launches to support both drugmakers
Announcement as on 16 September 2026

Aurobindo Pharma receives USFDA approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
Aurobindo Pharma announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol, 40 mcg and 80 mcg, a generic equivalent of QVAR Inhalation Aerosol 4
Announcement as on 15 September 2026

Aurobindo Pharma receives US FDA nod for metered Beclomethasone Dipropionate aerosol
Aurobindo Pharma said that it has received final approval from the US Food & Drug Administration (US FDA) to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol.
Announcement as on 15 September 2026

Company Announcement

Announcement as on 15 September 2026

Announcements by Aurobindo Pharma Limited first page | Next page |

AUROPHARMA Aurobindo Pharma Limited current price & indicator signals

Moving Averages for Aurobindo Pharma Limited

  • 5Day Average: 1668.24
  • 12Day Average: 1667.83
  • 20Day Average: 1654.57
  • 50Day Average: 1614.16
  • 100Day Average: 1547.98
  • 150Day Average: 1456.42
  • 200Day Average: 1389.9

AUROPHARMA Indicators & signals

Indicator MACD (12,26,9)

1665.86, 1648.91, 18.93
Indicator MACD is in positive zone

Indicator ADX (14)

17.68, 23.24, 16.26
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of AUROPHARMA Aurobindo Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
17 Thu Sep 2026 1690.00 1634.00 to 1692.30 2.86% 1.12 times
16 Wed Sep 2026 1643.00 1623.00 to 1657.10 -1.02% 0.77 times
15 Tue Sep 2026 1660.00 1642.10 to 1688.00 -1.18% 0.65 times
11 Fri Sep 2026 1679.80 1655.50 to 1681.40 0.68% 0.73 times
10 Thu Sep 2026 1668.40 1655.00 to 1693.40 -1.8% 1.18 times
09 Wed Sep 2026 1698.90 1672.00 to 1704.00 0.41% 0.89 times
08 Tue Sep 2026 1692.00 1655.00 to 1698.80 1.93% 1.56 times
07 Mon Sep 2026 1660.00 1646.00 to 1668.00 0.42% 0.79 times
04 Fri Sep 2026 1653.10 1622.60 to 1661.50 0.97% 0.85 times
03 Thu Sep 2026 1637.30 1626.60 to 1666.60 -0.66% 1.36 times
02 Wed Sep 2026 1648.20 1639.60 to 1695.00 -2.09% 1.21 times
01 Tue Sep 2026 1683.30 1671.10 to 1700.10 -1.96% 0.9 times

Videos related to: AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

AUROPHARMA announcements Aurobindo Pharma Limited announcements and dividends declared NSE

 

Back to top